CA2129676C - Dextromethorphan antitussive compositions - Google Patents

Dextromethorphan antitussive compositions

Info

Publication number
CA2129676C
CA2129676C CA002129676A CA2129676A CA2129676C CA 2129676 C CA2129676 C CA 2129676C CA 002129676 A CA002129676 A CA 002129676A CA 2129676 A CA2129676 A CA 2129676A CA 2129676 C CA2129676 C CA 2129676C
Authority
CA
Canada
Prior art keywords
per dose
composition
dextromethorphan
meq
cough
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002129676A
Other languages
English (en)
French (fr)
Other versions
CA2129676A1 (en
Inventor
Ronald Lee Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of CA2129676A1 publication Critical patent/CA2129676A1/en
Application granted granted Critical
Publication of CA2129676C publication Critical patent/CA2129676C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002129676A 1990-10-31 1991-10-21 Dextromethorphan antitussive compositions Expired - Fee Related CA2129676C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60629490A 1990-10-31 1990-10-31
US606,294 1990-10-31

Publications (2)

Publication Number Publication Date
CA2129676A1 CA2129676A1 (en) 1992-05-14
CA2129676C true CA2129676C (en) 1997-09-30

Family

ID=24427392

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002129676A Expired - Fee Related CA2129676C (en) 1990-10-31 1991-10-21 Dextromethorphan antitussive compositions

Country Status (13)

Country Link
EP (1) EP0555411A1 (ja)
JP (1) JPH06502428A (ja)
AU (1) AU663857B2 (ja)
CA (1) CA2129676C (ja)
CZ (1) CZ79593A3 (ja)
FI (1) FI931934A (ja)
HU (1) HUT64216A (ja)
IE (1) IE913792A1 (ja)
MX (1) MX9101831A (ja)
PL (1) PL168968B1 (ja)
PT (1) PT99380B (ja)
SK (1) SK42593A3 (ja)
WO (1) WO1992007559A1 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1274026B (it) * 1994-03-01 1997-07-14 Acraf Composizione antitosse
SE9601528D0 (sv) 1996-04-23 1996-04-23 Pharmacia Ab Transdermally administered dextromethorphan as antitissue agent
CA2298464A1 (en) 1997-07-15 1999-01-28 Walter Burghart Method for producing stable acetylsalicylic acid solutions
US6245785B1 (en) * 1998-11-30 2001-06-12 Warner Lambert Company Dissolution of triprolidine hydrochloride
US6846495B2 (en) * 1999-01-11 2005-01-25 The Procter & Gamble Company Compositions having improved delivery of actives
DE102007000521A1 (de) 2007-10-18 2009-04-23 Renate Conrad Hustenpräparat
CN110177542A (zh) * 2016-11-28 2019-08-27 强生消费者公司 包含黏膜粘着剂的液体组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4294819A (en) * 1980-08-18 1981-10-13 Bristol-Myers Company Alkaline analgesic capsule
US4454140A (en) * 1982-09-07 1984-06-12 Hoffmann-La Roche Inc. Nasal administration of dextromethorphan
US4427681A (en) * 1982-09-16 1984-01-24 Richardson-Vicks, Inc. Thixotropic compositions easily convertible to pourable liquids
US4892877A (en) * 1987-10-27 1990-01-09 Richardson-Vicks Inc. Antitussive liquid compositions containing phenol

Also Published As

Publication number Publication date
AU663857B2 (en) 1995-10-26
PT99380B (pt) 1999-04-30
AU8915891A (en) 1992-05-26
CZ79593A3 (en) 1994-01-19
IE913792A1 (en) 1992-05-22
PT99380A (pt) 1992-09-30
CA2129676A1 (en) 1992-05-14
JPH06502428A (ja) 1994-03-17
WO1992007559A1 (en) 1992-05-14
FI931934A0 (fi) 1993-04-29
PL168968B1 (en) 1996-05-31
EP0555411A1 (en) 1993-08-18
SK42593A3 (en) 1993-09-09
MX9101831A (es) 1992-06-05
HUT64216A (en) 1993-12-28
HU9301254D0 (en) 1993-07-28
FI931934A (fi) 1993-05-31

Similar Documents

Publication Publication Date Title
US5196436A (en) Dextromethorphan antitussive compositions
US9492541B2 (en) Phenylepherine containing dosage form
CA2183746C (en) Oral vehicle compositions
US5859060A (en) Timed release tablet comprising naproxen and pseudoepherine
JPH09502201A (ja) プロピオン酸非ステロイド系抗炎症剤のアミノ酸塩とうっ血除去剤、去痰剤、抗ヒスタミン剤及び鎮咳剤のうち少くとも１種を含有した組成物
AU4930793A (en) Pharmaceutical compositions and methods for treating cold symptoms
NO323022B1 (no) Anvendelse av et preparat omfattende en analgetikakombinasjon, oral formulering, og fremgangsmate for fremstilling av formuleringen.
JP2769696B2 (ja) 月経困難症及び／又は月経前症候群の軽減用薬剤組成物とその調製法
CA2129676C (en) Dextromethorphan antitussive compositions
US20030039687A1 (en) Taste masking composition
JPH10501235A (ja) 速溶解性剤形
CA2151912A1 (en) Use of s(+) antipodes of analgesic agents for the manufacture of a composition to treat respiratory disorders
NO309965B1 (no) Oralt farmasøytisk antihostepreparat
US10098856B2 (en) Alternating sympathomimetic therapy for the treatment of respiratory ailments
JPH11510168A (ja) 呼吸障害を処理するための鎮痛剤及び抗ヒスタミン剤を含有する組成物及び方法
EP0529898A1 (en) Potentiation of the antitussive effect of dextromethorphan with acetaminophen (paracetamol)
EP1303257B1 (en) Method of preparing a liquid unit dosage form and a kit
US5998478A (en) Timed release tablet comprising naproxen and pseudoephedrine
JP3150642B2 (ja) 新規な抗痙攣性及び抗炎症性組成物並びにそれらの製造方法
JP2000095707A (ja) 苦味を有する薬物を含有する口中溶解型又は咀嚼型固形内服医薬組成物
US6099860A (en) Controlled release oral preparation with naproxen sodium and pseudoephedrine

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed